Ana Cerdeira

Ana Cerdeira has a vast and varied work experience in the pharmaceutical industry. Ana has held leadership roles at companies like Grünenthal Group, Molecular Partners AG, Takeda Pharmaceuticals, The Janssen Pharmaceutical Companies of Johnson & Johnson, and Tecnimede Group. Ana's roles have encompassed project leadership, strategic planning, portfolio management, and business development, showcasing their expertise in commercial and early-stage strategy, due diligence for licensing and M&A projects, and global portfolio management. Their experience spans from research positions at the University of Lisbon to vice president positions overseeing global commercial and development assets.

Ana Cerdeira holds a Master's degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon, obtained in the years 1989-1994. Ana later pursued a PhD in Pharmaceutical Sciences at ETH Zürich from 2006-2012. Additionally, Ana has certifications in Design Excellence and Six Sigma from Johnson & Johnson and Stanwick in the years 2007-2009. Ana has also completed executive education programs in areas such as Digital Business Strategy from Massachusetts Institute of Technology, Transition to General Management from INSEAD, and Takeda Marketing Academy from The Wharton School in the years 2016-2018.